Product Name
HepG2 Cell Line
Expression System
Mammalian Expression System
Concentration
Approximately 5 × 106 cells/vial
Application
This in vivo validated tumor cell line is designed for tumor modeling and preclinical evaluation of anticancer therapies. It enables assessment of tumor formation, growth kinetics, and therapeutic response in established models, and can be used for efficacy studies, pharmacological evaluation, and mechanism-of-action investigations in oncology research.
Growth Conditions
1640 + 10% FBS
Morphology
Epithelial cell-like
Growth Properties
Adherent
Mycoplasma Status
Negative
Storage
90 % FBS + 10 % DMSO
Vapor phase of liquid nitrogen
Shipping Conditions
Dry Ice
Description
Curve of HepG2 (human liver cancer) cell subcutaneous tumor formation in mice.
Tumor bearing: Subcutaneous injection of 5 × 106 HepG2 cells into the right back of mouse.
Strain: NSG mouse (Female, 6-8W, N=5)
Administration node: D25
Industry Terms
Not Available to Industry
